Skip to content | Change text size
 

PhD Research Topics and Supervision

Prospective PhD candidates seeking to develop a research topic and find a research supervisor are invited to inquire about the research projects and research groups listed below. Please follow the link from the title for contact details and further information.

Prospective candidates should also consult the School's Research web page which lists academic staff and their research interests, and other research groups, centres and affiliations that welcome inquiries regarding research projects and supervision


Clinical Cognitive Neuroscience

Overview

Julie Stout is interested in understanding how the brain, especially the striatal-frontal brain systems, implement complex adaptive behaviours, such as decision making, social functioning, and emotions processing.  Her laboratory also has a particular interest in understanding and describing how behaviour is affected by damage to the basal ganglia.  Her current research methods include experimental cognitive and clinical neuropsychological testing, and cognitive modeling.  Research projects include investigations of decision making in drug abuse, and basal ganglia and cognition in presymptomatic Huntington's disease.

Risky Decision Making in Substance Abusers Study

Overview: The neostriatal structures function as components in brain circuits that have regionally specific constituents in the frontal lobes, with projections to the striatum, and then via additional structures, feed back into the same area of frontal cortex. Theories about this brain circuitry suggest that damage in the frontal cortical regions or in the other projection regions of the circuit can produce similar dysfunction of the circuit and thus behavioural disruptions may appear similar regardless of the level at which the neural circuit is disrupted.

Our research program has developed formal modeling approaches to analyze the performance of complex problems in different clinical populations. One task that has been of major interest and has led to productive research is the Iowa gambling task. The Iowa gambling task, developed by Bechara, Damasio, Tranel and Anderson (1994) has drawn attention in the decision-making literature since patients with pre-frontal ventromedial lesions were found to have poor performance on the task. Poor task performance has also been found in other clinical populations, including drug abusers, Huntington disease patients, and individuals with an antisocial personality disorder. These results suggest that different mechanisms are responsible for the poor task performance exhibited by these clinically different populations.

Recently, Busemeyer and Stout (2002) used a formal model to decompose performance in the Bechara gambling task into learning, motivation, and decision-making components. This approach has been found useful for understanding the different patterns observed in diverse clinical populations. For example, it appears that Huntington patients perform poorly in this task due to a tendency to focus on recent outcomes and to forget outcomes from less recent choices. In contrast, cocaine addicts seem to exhibit poor performance because of their tendency to focus on gains and ignore losses. A large portion of the testing for this study will be conducted at Monash University in a short period of time.

Huntington's Disease (HD) Overview

Huntington disease is an autosomal dominant disease that typically shows onset in adulthood and is fully penetrant. That is, individuals with the Huntington disease gene (an expansion of the CAG triplet repeat on the short arm of chromosome 4) have a fifty percent probability of passing on the Huntington gene to each of their offspring. There has been a long line of research documenting the presence of Huntington-related symptoms prior to the onset of chorea. These symptoms, which encompass psychiatric, cognitive, motor, and other behavioral and personality disturbances have been reported retrospectively in many clinical studies. Prospective documentation for these symptoms, and a timeline that defines the onset and progression of symptoms prior to meeting the chorea-defined diagnosis, has been much more elusive.

HD ToolKit Study

The HD Toolkit project seeks to identify a set of optimal tests and assays for use in clinical trials of compounds that have the potential to delay the onset and/or the progression of HD. As such, we believe this is an important step toward our ability to offer hope to those who are genetically predisposed to HD and their families.  This study is currently being conducted at Julie Stout's Laboratory at Monash University.

Predict-HD Study

This is a multi-site study, led by Jane S. Paulsen at the University of Iowa, which investigates the nature and pattern of neurobiological changes and neurobehavioral changes that occur in the period leading up to a diagnosis of Huntington's Disease. The goal of this study is to learn more about the initial changes in cognitive abilities, emotional regulation, brain structure and brain function as a person begins the transition from health. Our role in the study is to develop and implement the cognitive battery, as well as ensure the quality of these data and their analysis. Portions of this study are scheduled to be conducted at Julie Stout's Laboratory at Monash University.

Track-HD Study

This is a multi-centre, multi-national prospective, observational biomarker study of premanifest and early stage HD with no experimental treatment. Current sites are in Vancouver Canada, Leiden Netherlands, London, and Paris. It will be used to examine the sensitivity of individual and combined clinical and biological outcome measures for tracking progression of HD. The goal is to develop the much-needed methodology to undertake future clinical trials of disease-modifying agents in this group of HD patients. Cognitive aspects of this study are being monitored at Julie Stout’s Laboratory at Monash University.

Objective: To find out what combination of measures is the most sensitive for detecting change over the natural course of HD, with a view to validating these measures for use in future therapeutic trials.

Contact:
Professor Julie C. Stout
Telephone: +61 3 9905 3987
Fax: +61 3 9905 3997
Email: julie.stout@med.monash.edu.au


Cognitive Neuropsychiatry

Potential PhD projects are available exploring the cognition and underlying neurobiology of the three major positive symptoms of psychosis: auditory hallucinations, delusions and thought disorder. My research uses a variety of techniques including cognitive science, neuroimaging (EEG and fMRI), eye tracking, and ketamine modelling. My studies involve a range of different populations that experience positive symptoms of psychosis including: schizophrenia, bipolar disorder, body dysmorphic disorder, Traumatic Brain Injury, Alzheimer’s disease and anorexia.

Contact:
A/Professor Susan Rossell
Alfred Psychiatry Research Centre
Telephone: 9076 8650
Email: susan.rossell@med.monash.edu.au


Social Sciences and Health Research Team

1. Immigration and parenting among Cambodian and Iraqi women in Australia

This project explores the interrelationships between immigration, personal and family identity, and motherhood in contemporary Australia. It explores how motherhood is influenced by changes in the community structures, the organization of domestic and paid work, and communication systems, and elucidates how the practices of parenting are influenced by the social, cultural and political contexts of global and local society as well as specific migration histories. The project is innovative methodologically and in its application of the frameworks of social capital and transnationalism as a means to understand the interrelationships of migration and motherhood.

2. Care-seeking, use of CAM, and self-management among people with Type 2 Diabetes and Cardiovascular Disease

Chronic disease and related health problems are increasing in prevalence in Australia. Recent estimates suggest that Type 2 diabetes and heart disease cost the Australian community almost $9 billion in direct costs per annum. People with chronic conditions follow medical and behavioural prescriptions variably, however, while also using complementary and alternative (CAM) therapies, practitioners, vitamins and herbs. We will explore the reasons for presentation to and use of CAM practitioners and therapies by people diagnosed with and under treatment for two of the most commonly diagnosed chronic conditions – cardiovascular disease and diabetes – in order to establish the relationship with adherence to their prescribed treatment. The focus is on what is described as the "drivers, costs and benefits" of the use of CAM, and how the practical interaction of CAM and conventional health care approaches may support adherence. This research program will have very important implications for the control of these diseases and individual wellbeing. Using an innovative interdisciplinary approach and a mix of research methods, the research will provide a unique evidence-base on community approaches to and use of complementary and alternative medicine, and the significance of this to current and future health needs. The program will take advantage of the interdisciplinary skills in novel ways to explore areas of health and society that have so far received limited attention. By including two PhDs, we will strengthen Australia’s research capacity in health social sciences and public health in this field, generating new skills important to population health practice and policy in this country.

3. Enhancing social connectivity, improving health outcomes: a computer-based social support and health information intervention program for elderly amputee inpatients

This project takes as its starting point data collected in a study of the social factors which influence adaptation to lower limb amputation in regional and urban Victoria and seeks to use the knowledge gained in this study about recent amputees' access to health information and social support to develop an intervention to address some of the issues faced by participants. The proposed project also seeks to fill some existing gaps in current amputee rehabilitation services, as identified by members of the multidisciplinary amputee rehabilitation team (which includes: rehabilitation consultants, prosthetists, physiotherapists, nurses, occupational therapists, podiatrists, and dieticians).

Contact:
Professor Lenore Manderson
Email: Lenore.Manderson@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/staff/lmanderson.html


High risk behaviours and social cognition in mental disorder

Potential doctoral projects are available investigating the possible relationships between deficits in social cognition and high-risk behaviours such as aggression, self-harm and vulnerability to victimisation in people with mental disorders.

The projects would be auspiced by the Centre for Forensic Behavioural Science, a specialist centre within SPPPM.

Contact:
Dr Andrew Carroll
Email: Andrew.Carroll@med.monash.edu.au for further discussion


Perceptual and Clinical Neuroscience

  • mechanisms of perceptual rivalry
  • visual and attentional processing, especially during perceptual rivalry
  • aberrations of perceptual rivalry in clinical psychiatric groups, especially bipolar disorder
  • vestibular stimulation in the treatment of mania, depression and other psychiatric conditions
  • vestibular stimulation in the treatment of persistent (chronic) pain states
  • vestibular stimulation in studies of cerebral laterality, cognitive style and decision-making
  • vestibular stimulation and experimental neurophilosophy
  • foundational (theoretical/philosophical) issues in the scientific study of consciousness

Contact:
Dr Steven Miller
Perceptual and Clinical Neuroscience Group
E-mail: Steven.Miller@med.monash.edu.au
Web: www.pcng.org.au


Astrocytes, Ageing and Brain Dysfunction

Much of the brain damage in Alzheimer’s disease, Parkinson’s disease and stroke is due to iron-mediated oxidative stress. Our team investigates how brain cells protect themselves from iron and oxidative stress. Our research is leading towards new treatments for these diseases.

Contact:
Assoc. Prof. Stephen Robinson
Telephone: +61 3 9905 3950
Email: stephen.robinson@med.monash.edu.au
Dr. Glenda Bishop
Telephone: +61 3 9905 4564
Email: glenda.bishop@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/astrocytes/


Reducing the Illness Burden: Health and Psychological Medicine Research Program

This research program consists of closely linked undergraduate and post-graduate projects investigating the psychosocial aspects including biological understanding, anxiety, coping and initial management, parenting and attachment, and the impact of health condition educational interventions on illness perceptions in children and their families experiencing one of five health conditions. These are Congenital Heart Defect (CHD); Renal System Abnormalities (incontinence, dialysis, transplant); Insulin Dependent Diabetes Mellitus (IDDM); Cystic Fibrosis; and Childhood Obesity. Active research collaborations with specialist paediatricians are established at Southern Health (Professor Samuel Menahem, paediatric cardiologist; Dr Amanda Walker, paediatric nephrologist; Associate Professor Christine Rodda and Dr Philip Bergman, paediatric endocrinologists) and The Royal Children’s Hospital (Dr Michael Harari, Dr Melissa Wake and Dr Harriet Hiscock (paediatricians).

The research group is based at The Alfred Psychiatry Research Centre, Old Baker Building, The Alfred Hospital, Prahran.

HDR candidates are sought for a range of projects investigating the impact of biological knowledge of children’s understanding and management of their chronic health condition, and the impact of the chronic illness on parenting, attachment, family and child psychosocial functioning. There is also increasing evidence that people with compromised mental health have poorer outcomes for a range of physical health conditions, and that poor mental health has a negative impact on treatment and management of chronic illness. An emerging area of research is centered on this physical/mental health interface across a range of chronic health conditions.

Contact:
Dr Margaret Hay
Email: margaret.hay@med.monash.edu.au  or m.hay@alfred.org.au

Specific Projects available in 2009

Congenital Heart Defect

Determining the content of a multimedia educational program for parents of pre-natal diagnosed congenital heart defect (CHD)

This qualitative study aims to determine the type of information that would be relevant and beneficial to parents experiencing a pre-natal diagnosis of CHD through interviews with parents who have been through such an experience.

The development and evaluation of a multimedia educational program for parents of pre-natal diagnosed congenital heart defect (CHD).

This project will develop and evaluate the impact of a psychosocial educational program on CHD to determine the impact of this education on parents’ knowledge of CHD, their coping and psychosocial wellbeing following a pre-natal diagnosis of CHD.

Diabetes

The development and evaluation of a multimedia educational program for children with Type 1 Diabetes Mellitus.

This project will develop and evaluate the impact of an educational program on children’s understanding of the biological systems relevant to diabetes and its required management. The impact of this education on children’s psychosocial wellbeing will also be explored.


Experimental Neuropsychology

Potential PhD projects are available exploring selective attention and other cognitive processes that are closely related or even overlap, such as working memory, sustained attention or vigilance, divided attention, etc. For instance, one particular research focus at present is understanding which aspects of cognition deteriorate with age, and the processes that underlie that deterioration.

Potential research projects:

  • Cognition and attention in the elderly, Parkinson’s disease (PD) and the contribution of depression
  • The use of experimental neuropsychological tools to differentiate individuals with ADHD with and without comorbid disorders, such as autism, conduct disorder, etc
  • Cognition and attention in children with various types of intellectual disability compared to normally-developing children

Contact:
Dr Dianne Sheppard
Telephone: +61 3 9905 1498
Email: dianne.sheppard@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/staff/dsheppard.html


Pathophysiology of disordered affective processing in mood disorders

The role of inhibitory brain activity in depression and schizophrenia

Potential PhD projects are available exploring the pathophysiology of disordered affective processing in mood disorders and the role of inhibitory brain activity in depression and schizophrenia. These studies could potentially utilize techniques such as imaging, transcranial magnetic stimulation and EEG.

Contact:
Professor Paul Fitzgerald
Alfred Psychiatry Research Centre
Telephone: 9076 6552
Email: paul.fitzgerald@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/aprc/staff/paulf.html


Anxiety and Depression in Primary Care

Health Communication

General Practitioner support strategies

Primary Mental Health Care

The Primary Mental Health Team, Alfred Psychiatry Research Centre, has a clinical focus on anxiety and depression in primary care, as well as health communication, in both the verbal and written form.  The Team has an interest in research in the following areas:

  • Health communication: Communication between patients and health care providers, the relationships between health care providers, and pathways to care.
  • Evaluating effective practices for people with anxiety and depression in general practice
  • General Practitioner support strategies

Contact:
Fiona Foley
Telephone: 9804 4444
Email: f.foley@alfred.org.au
Or, from October,
Dr Rob Selzer
Telephone: 9804 4444
Email: r.selzer@alfred.org.au


Psychopharmacology and Endocrinology

Behavioural and Cellular Neurosciences

My research interest and expertise are in the area of psychopharmacology and endocrinology.
General research area membership:  Behavioural and Cellular Neurosciences
Possible projects for PhD research include:

  • the measurement of psychoactive drugs (drugs of abuse as well as those prescribed to treat mood disorders) with respect to behavioural and endocrinological outcomes;
  • treatment for chronic pain - cognitive and functional outcomes;
  • neurosteroids and sleep - a novel approach to hypnotics.

Project 1:

Do neurosteroids have utility in the treatment of insomnia without causing the deleterious changes in sleep architecture that limit current prescription remedies? 

Co-supervised by Professor Colin Goodchild.
Problems getting to sleep or staying asleep are common to people of all ages.  Neurosteroidal drugs that modulate the GABAa receptor subtype result in sedation (similar to what we see with benzodiazepines) however there is evidence that neurosteroids don’t change sleep architecture.  By contrast, use of a typical GABAa agonist will shorten sleep onset, but at the expense of both deep and REM sleeps. This has deleterious effects on arousal and cognition the following day.  This project will investigate a novel neurosteroid in humans, examining cognitive function and sleep quality using EEG, in comparison with a commonly prescribed sleeping medication.

Project 2:

Investigation of the effects of exercise on measures of depression and anxiety-like behaviour in the rat

While many of us have experienced (and look for) the benefits of regular exercise on our mood and sense of well-being, there are few basic studies that have examined the effect that regular exercise has on measures of antidepressant- and anxiolytic-like behaviours.  This project will examine the effects of exercise, drug treatment, time of day and rat strain on the efficacy in commonly used animal models.
Variables may include exercise duration (access to running wheel; record how much exercise each animal does; how many day’s/weeks the exercise is available); drug treatment (carbetocin, imipramine, alprazolam (solubility issues)); rat strain (Sprague Dawley versus Wistar-Kyoto); behavioural test (open space, open field, plus maze?).The potential application of these findings to humans will be investigated.
Background Reading:
Russo-Neustadt A, Ha T, Ramirez R, Kesslak J.P. (2001) Behav Brain Res 120:1, 87-95.
Solberg L.C., Horton T. H., Turek F. W. (1999) Am J Physiol Regul Integr Comp Physiol 276:1 (45-1), R152-161

Project 3:

Roles of pituitary hormones in animal models that are predictive of antidepressant efficacy

As well as their well-described hormonal effects in the periphery, oxytocin and vasopressin are known to be neuromodulators in the central nervous system.  They are particularly important in the control of reproductive behaviours, affiliative behaviour, aggression and mood.  This project will continue the investigation of oxytocin commenced in 2006, to build on our pilot findings of its having antidepressant- and anxiolytic-like activity in rat behavioural paradigms.  It will also investigate the utility of the vasopressin receptor system in modulating these behaviours.
Background Reading:
Arletti, R., & Bertolini, A. (1987). Oxytocin acts as an antidepressant in two animal models of depression. Life Sciences, 41, 1725-1530.
Jorgensen, H., Riis, M., Knigge, U., Kjaer, A., & Warberg, J. (2003). Serotonin receptors involved in vasopressin and oxytocin secretion. Journal of Neuroendocrinology, 15, 242-249.

Project 4:

Is there an endocrinological basis for the perceived differences between MDMA (‘ecstasy’) and amphetamine?

MDMA has stimulant properties, but has a number of unique attributes that put it in a class of its own.  This project is to investigate what makes MDMA different, and where the biological basis for this difference may lie.  A drug discrimination model will be used, in which rats are trained to report whether they have been treated with MDMA, amphetamine or saline.  Then a variety of pharmacological manipulations will be used to determine whether endocrinological changes that take place following MDMA are important determinants of its perceived (interoceptive) effects.  A second aspect to this project is an examination of the behavioural outputs of MDMA and amphetamine administration, specifically looking at affiliative behaviour in rat social interactions and determining whether changes in the interoceptive effects of these drugs translates to behavioural change.  This overall project would be suitable for two students.
Background Reading:
Oberlender R, Nichols DE. (1988) Psychopharmacology 95(1):71-6
K.C. Morley, J.C. Arnold and I.S. McGregor (2005) Prog Neuropsychopharmacology Biol Psychiat 29
Contact:
Dr. Jillian Broadbear
Telephone: 9905-3903
Email: jillian.broadbear@med.monash.edu.au)
Web:  http://www.med.monash.edu.au/spppm/research/staff/jbroadbear.html


Implementation and evaluation of Acceptance and Commitment Therapy/Training (ACT) for

  • children, adolescents, parents and/or schools, or
  • health care providers (e.g. mental health clinicians; A&E staff; or child and maternal health).

Further information:

Acceptance and Commitment Therapy/Training (ACT), based on Relational Frame Theory, is increasingly growing in popularity with clinicians working across surprisingly diverse client groups.  Since its debut in 1999 it has been found to be effective in studies ranging from the treatment of severe conditions, such as borderline personality disorder, to performance improvement interventions, such as sports psychology and workplace productivity. 
Given its recent arrival into psychology and psychiatry, there is significant need for research concerning ACT.  I am particularly interested in population education/training approaches for delivering ACT.  PhD projects in this area could, for example, involve developing/adapting new materials for ACT education/training for a particular group (i.e. classrooms; high-risk new parents; health care provider groups; etc.), implementing the ACT intervention and evaluating outcomes (using qualititative and quantitative measures).
I believe this population-delivery approach has significant potential advantages for (a) preventative health care,(b) increasing productivity and wellbeing in the chosen population, and (c) decreasing 'hidden' impairment in the community.
As I am a clinical child and adolescent psychologist, as well as a senior lecturer within SPPPM, I am particularly interest in supervising ACT research with children, adolescents, parents and schools. 
If you would like to discuss this area of research further, please contact:
Dr Cate Bearsley Smith
Telephone: 5173 8181 or 0422 224 505
Email: cate.bearsley-smith@med.monash.edu.au  
Web: http://www.med.monash.edu.au/spppm/research/staff/cbs.html


Multi-family groups for traumatic brain injury

Headstrong

Multi-family groups for traumatic brain injury.  A clinical research program for the study of the impact of multi-family group intervention on the social and psychological functioning of people with traumatic brain injury and their care givers

In the absence of substantive controlled trials of family based interventions for families living with TBI, Headstrong will evaluate the efficacy of an evidence-based multi-family group intervention.  The project will adapt a well-researched Multi-family Group (MFG) program, previously developed for mental illness, implement it in a series of treatment groups of 60 individuals with TBI and their families, and evaluate its efficacy. This will be over a 3 year period commencing in 2008, pending confirmation of funding. 
The program will study the benefit, for people with TBI and their care givers, in terms of use of attendant care and respite services, community integration, behaviour management, and psychological well-being.  The project is designed such that a control component is embedded in the form of variable waitlist protocols which enable all participating families to have access to the intervention while ensuring high quality empirical evidence.  Effective interventions which promote optimal family functioning after trauma are important to minimise the burden these injured individuals place on the health care and community service system, due to their poor cognitive, behavioural, social and psychological functioning.   
As a PhD project, headstrong would offer opportunities for the researcher to develop both research and clinical skills.  The researcher would be required to conduct structured interviews and questionnaires with people with TBI and their families.  The preference would be for a thesis by publication as the findings would be relevant to current international clinical research programs.
Contact:
Dr Grace Couchman
Telephone:  95487011
Email: Grace.Couchman@med.monash.edu.au


Self-Harm and Suicide Prevention

The Self-Harm and Suicide Prevention Research Group is a multidisciplinary team of researchers and clinicians with an interest in understanding and managing self-harm and suicidal behaviour. Projects are available for PhD students interested in working in any area of suicide prevention. Currently projects are being conducted in the areas of:

  • Self-injury in adolescents and young people
  • Community attitudes towards self-harm
  • Education and training of professionals who encounter young people who self-harm
  • The roles of attachment and peer support in self-harm

Future projects may include:

  • Evaluation of online services for young people with mental health issues
  • The role of media in self-harm and suicide
  • Attitudes and knowledge of educators regarding self-harm and mental health issues among young people

Dr. Penelope Hasking supervises research projects in two primary areas: 1. suicide prevention and 2. cognitive and behavioural factors associated with substance use.
PhD students interested in either area are encouraged to contact Dr Hasking to discuss opportunities.
Dr. Penelope Hasking
Telephone: 9903 1148
Email: Penelope.Hasking@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/staff/phasking.html


Positive psychology research group

Positive psychology focuses on identifying character strengths and applying these to create a worthwhile and satisfying life.  Positive psychology also examines how the various pathways to happiness such as pleasure, engagement and meaning influence health and well-being.

  • Research is needed to examine the efficacy of positive psychology interventions aimed at increasing well-being and happiness.  Examples of positive psychology interventions include applying strengths in novel ways, learning to savour positive experiences, expressing gratitude and envisioning what you at your best would be like.  An evaluation of the lasting effects of these interventions on mental health and well-being in different contexts is needed (e.g., education, workplaces, health, relationships).
  • Another possible research project involves examining how the various pathways to happiness such as pleasure, engagement and meaning influence health and well-being and whether there is an optimal level of each of these happiness pathways for well-being. Is it possible to increase happiness via these three orientations to happiness?  Does this outcome depend on personality traits, personal goals or life stage?
  • Experience sampling method can be employed to explore the frequency and importance of life experiences which can be categorised as pleasurable, engaging, or meaningful, or combinations of these.  How do these experiences align with existing measures of happiness or more objective indicators such as physical health or number of sick days off work?  How important are factors such as frequency, ratio and intensity of experience in relation to pleasure, engagement and meaning for attaining desirable health outcomes (e.g., social, mental, physical health)?

Contact:
Dr Dianne Vella-Brodrick
Email: Dianne.vella-brodrick@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/staff/dvbrodrick.html


Aged mental health

PhD research in the areas of:

  • Mental health in aged residential facilities
  • Psychosocial treatments of behavioural and psychological symptoms of dementia
  • General practitioners' treatment of older patients with mental illness

Contact:
Professor Daniel O’Connor
Email: Daniel.OConnor@med.monash.edu.au


Clinical and health psychology

Prospective doctoral students are very welcome to talk to Professor Paul Martin about research projects in clinical and health psychology. Paul has a long standing interest in headache and migraine. A current funded-project in this domain is on developing and evaluating an integrated approach to treating co-morbid chronic headache and depression. Funding is being sought for research on behavioural management of the triggers of headaches, which challenges the conventional wisdom that the best way to prevent headaches is to avoid the factors that trigger them.

Paul’s research interests include disorders related to headaches, such as chronic pain, stress, anxiety and depression. He is a chief investigator on a project evaluating an intervention to prevent depressive relapse, and is a co-author of a book on postnatal depression.

Paul has developed and evaluated an intervention (Promoting Social Networks and Support) to assist people increase the size of their social network and derive more support from it, and thereby cope better with stress. He has also developed a web site for assessing cardiovascular risk (HEARTbehaviour). The latter reflects his interests in internet assessment and interventions on the one hand, and how behaviour and lifestyle relate to health on the other.

Doctoral projects could be developed in any of the above domains.

Contact:
Professor Paul Martin
Telephone: 9594 1468
Email: Paul.Martin@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/staff/pmartin.html


Qualitative Theoretical Psychoanalytic Research

Qualitative research in:

  • Psychological Medicine (topics related to psychoanalysis, psychotherapy, psychoanalytic group work)
  • Interdisciplinary projects including philosophy and conceptual analysis, history, biography, literature, religion.

Contact:
Dr. Jocelyn Dunphy-Blomfield
Convenor QTP Research Stream Seminar
Email: jocelyn.dunphy-blomfield@med.monash.edu.au


Chronic Somatoform Pain Disorder

'Biological Markers in Chronic Somatoform Pain Disorder and Co Relation with Progress/Improvement of the Pain and associated Depressive and Anxiety symptoms with different modalities of Treatment'. For further information contact:
Dr. Nitin Dharwadkar
M.B.B.S., M.D., F.R.A.N.Z.C.P.
Consultant Psychiatrist
Hon. Senior Lecturer
Email: Nitin.Dharwadkar@med.monash.edu.au


Music psychology

We have a broad range of research programs available in music psychology:

1)  Enrichment and Engagement

the behavioural and cognitive benefits of various forms of musicianship, ranging from formal music training and performance and school-based music education to affective and social involvement in music activities

2)  Neuromodulatory effects of music

the physiological effects of music on neurotransmitter systems which regulate emotional memory and anxiety

3)  Music therapy

the neuropsychological effects of music therapy in populations experiencing dysfunction of some kind (eg., dementia, depression)

Contact for topics 1 and 2:

Associate Professor Nikki Rickard

Email: nikki.rickard@med.monash.edu.au

Web: http://www.med.monash.edu.au/spppm/research/staff/nrickard.html

 

Contact for topic 3:

Dr Samia Toukhsati

Email: samia.toukhsati@med.monash.edu.au

Web: http://www.med.monash.edu.au/spppm/research/staff/stoukhsati.html


Sleep research PhD – Australia-USA collaboration

http://www.med.monash.edu.au/spppm/pgrad/sleep-res.html


Sleep research – other projects

Contact:
Dr Shanthakumar Rajaratnam
Email: Shantha.Rajaratnam@med.monash.edu.au
Web: http://www.med.monash.edu.au/spppm/research/staff/swr.html
Dr Russell Conduit
Email: russell.Conduit@med.monash.edu.au


Animal Welfare

Prof. Grahame Coleman
Email: Grahame.Coleman@med.monash.edu.au
Dr Pauleen Bennett
Email: Pauleen.Bennett@med.monash.edu.au
Dr Samia Toukhsati
Email: Samia.Toukhsati@med.monash.edu.au


Psycho-oncology

Psycho-oncology involves research into the psychological experience of cancer patients and their families regarding screening, diagnosis, treatment decision making and end-of-life issues. As Head, Cabrini Monash Psycho-oncology Research Institute I am working closely with medical oncologists and other specialists at Cabrini Health, a large private hospital in Melbourne with the largest throughout of cancer patients in Victoria . Therefore there are many research opportunities for psychology postgraduate student, particularly in relation to anxiety, depression and quality of life across all tumour streams.

Dr Sue Burney
Email: Susan.Burney@med.monash.edu.au